---
title: "Nasdaq Futures Jump 357 Points as Earnings Season Heats Up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293346510.md"
description: "Nasdaq futures surged 357 points as earnings season overshadowed Middle East tensions. Risk-on sentiment returned, with chip stocks and blue-chip earnings like 3M driving gains. Global markets rose: Japan's Nikkei up 3.3%, China's Shanghai Composite up 1.8%, and European indices higher. Key corporate news includes Novo Nordisk suing Eli Lilly, Nvidia taking a stake in Nebius, and Steel Dynamics sliding despite earnings beats."
datetime: "2026-07-21T13:05:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293346510.md)
  - [en](https://longbridge.com/en/news/293346510.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293346510.md)
generator: "portal-rs"
---

# Nasdaq Futures Jump 357 Points as Earnings Season Heats Up

Futures on the Nasdaq-100 Index (NDX) and Dow Jones Industrial Average (DJI) are up triple digits this morning, with chip stocks and risk-on appetites overshadowing a continued flurry of **U.S-Iran tensions**. The U.S. has carried out 10 consecutive days of airstrikes, though mediators pushing for a 10-day ceasefire is keeping a cap on oil price gains today. Earnings season is an effective distraction from the Middle East instability, with blue chip 3M (MMM) up 6% before the bell after a beat-and-raise.

*Continue reading for more on today's market, including:*

-   How a **rangebound SPX** impacts the bulls vs. bears case, per Senior V.P. of Research Todd Salamone.
-   A **pre-earnings roundup** of GE Vernova stock.
-   Plus, Novo slams Eli Lilly with lawsuit; steel stock slides; Nvidia bets on Nebius.

## 5 Things You Need to Know Today

1.  The Cboe Option Exchange saw roughly 2.2 million call contracts and 1.4 million put contracts traded on Monday. The single-session equity put/call ratio fell to 0.66, while the 21-day moving average remained at 0.58.
2.  **Novo Nordisk (NYSE:NVO)** stock is down 0.7% before the bell, after the drugmaker filed a lawsuit against rival Eli Lilly (LLY), citing misleading advertising for its GLP-1 drugs. Novo Nordisk also had a **GLP-1 dispute** with Hims & Hers Health (HIMS) earlier this year. NVO is below its year-to-date breakeven level, an area that roughly coincides with its 320-day moving average.
3.  **Steel Dynamics Inc (NASDAQ:STLD)** stock is off by1.3% in electronic trading, brushing off a top- and bottom-line beat after incurring a non-cash impairment charge of $16 million. Although STLD is 20% off its June 15 record high, the shares remain 36% higher **year-to-date.**
4.  **Nebius Group NV (NASDAQ:NBIS)** stock is up 6.8% in premarket trading, after Nvidia (NVDA) said it took a 9.3% stake in the cloud company. NBIS is up 118% in 2026 with support at the 120-day moving average.
5.  More **big name earnings** scheduled for this week.

## Earnings Boost European stocks

Asian markets closed mostly higher as crude cooled. Japan’s Nikkei returned from its holiday break with a 3.3% pop as traders rush back into the beaten down index. Elsewhere, China’s Shanghai Composite gained 1.8%, the South Korean Kospi jumped 3.6%, and Hong Kong’s Hang Seng inched 0.04% lower.

European bourses are higher too, while investors focus on today’s wave of corporate earnings. At last glance, London’s FTSE is rising 0.2%, Germany’s DAX is 0.2% higher, and France’s CAC is up 0.05%

### Related Stocks

- [000001.CN](https://longbridge.com/en/quote/000001.CN.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [MMM.US](https://longbridge.com/en/quote/MMM.US.md)
- [STLD.US](https://longbridge.com/en/quote/STLD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [NBIS.US](https://longbridge.com/en/quote/NBIS.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [NEBX.US](https://longbridge.com/en/quote/NEBX.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [NBIL.US](https://longbridge.com/en/quote/NBIL.US.md)
- [NVOH.US](https://longbridge.com/en/quote/NVOH.US.md)
- [QQQ.US](https://longbridge.com/en/quote/QQQ.US.md)
- [NBIG.US](https://longbridge.com/en/quote/NBIG.US.md)
- [ONEQ.US](https://longbridge.com/en/quote/ONEQ.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [QQQM.US](https://longbridge.com/en/quote/QQQM.US.md)
- [QQEW.US](https://longbridge.com/en/quote/QQEW.US.md)
- [QQQE.US](https://longbridge.com/en/quote/QQQE.US.md)
- [TQQQ.US](https://longbridge.com/en/quote/TQQQ.US.md)
- [QLD.US](https://longbridge.com/en/quote/QLD.US.md)
- [PSQ.US](https://longbridge.com/en/quote/PSQ.US.md)
- [SQQQ.US](https://longbridge.com/en/quote/SQQQ.US.md)
- [QID.US](https://longbridge.com/en/quote/QID.US.md)
- [NBIZ.US](https://longbridge.com/en/quote/NBIZ.US.md)
- [.NDX.US](https://longbridge.com/en/quote/.NDX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [GEV.US](https://longbridge.com/en/quote/GEV.US.md)
- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [00HSI.HK](https://longbridge.com/en/quote/00HSI.HK.md)
- [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md)

## Related News & Research

- [Evolve Private Wealth LLC Lowers Stock Holdings in Eli Lilly and Company $LLY](https://longbridge.com/en/news/297282696.md)
- [Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?](https://longbridge.com/en/news/297409652.md)
- [Eli Lilly's Taltz-Zepbound Combo Shows Encouraging Results At Week 52](https://longbridge.com/en/news/297510647.md)
- [Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label](https://longbridge.com/en/news/297356212.md)
- [BioArctic Q2 FY26 turns to net loss of SEK 11.2 million; revenue falls to SEK 247.5 million](https://longbridge.com/en/news/296992922.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**